The LOXL1 gene helps your body build and maintain elastic fibers, which give tissues like the eye, skin, lungs, and blood vessels their stretch and support. If this gene does not work properly, these fibers may form abnormally, and some tissues can become less resilient. Certain variants in the LOXL1 gene are linked to exfoliation syndrome, a condition where flaky material collects in the eye and can raise the chance of glaucoma. These variants influence risk, but they do not mean eye disease will definitely develop.
What is a gene?
Genes are stretches of DNA that hold instructions your cells use to make molecules or manage processes throughout the body. Some genes provide the directions for producing proteins, which are the parts of cells that do much of the work. Others are mainly involved in regulating when certain processes happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they may also influence how you respond to food, stress, and medications. For a deeper look at this topic, you can read more in the LearnHub.
Overview
LOXL1Gene function
What if the gene works
The LOXL1 gene helps your body build and maintain elastic fibers, which let tissues stretch and spring back. This supports connective tissue in places like the eye, skin, blood vessels, lungs, and pelvic floor.
Risk
What if the gene does not work
Variants in the LOXL1 gene are best known for increasing the chance of exfoliation syndrome, an eye condition that can lead to glaucoma. Effects range from little impact to earlier or more troublesome eye disease in some people.
Treatment
What does that mean for your treatment
No LOXL1-specific treatment or management approach is currently established for pathogenic or loss-of-function variants in the LOXL1 gene. The LOXL1 gene is being studied as a biomarker and possible drug target in exfoliation glaucoma, fibrosis, and some cancers, but this has not changed routine drug choices.
Conditions associated with LOXL1
Gene function
What if the gene works
Many body tissues need to bend, expand, and return to shape during everyday life. In your body, the LOXL1 gene supports this flexibility by helping form strong elastic fibers in connective tissue. This is central to normal LOXL1 gene function in connective tissue, especially in tissues that need stretch and recoil.
The LOXL1 gene helps join elastin building blocks so elastic fibers can form and mature. These fibers give tissues the ability to stretch and then return toward their usual shape.
Its protein helps create firm links between parts of the tissue support network outside cells. This strengthens elastic material and helps connective tissue stay resilient with normal movement and pressure.
LOXL1 works in the extracellular matrix (the support material outside cells). By helping maintain this framework, it supports the structure of tissues such as blood vessels, lungs, skin, and tissues around the eye.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help shape normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants do not lead to any noticeable effect and are simply part of natural genetic variation. In some situations, though, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the LOXL1 gene can change how much LOXL1 protein cells make, how well it is processed and released, or how effectively it links elastic fibers together outside cells. Milder variants often seem to shift gene activity or protein handling rather than switch it off, while more disruptive variants can sharply reduce protein stability or enzyme activity. This spectrum helps explain how LOXL1 gene variants affect protein function and why some are linked to earlier or more marked eye findings.
How variants are linked to conditions
Variants in the LOXL1 gene are most clearly linked to exfoliation syndrome, an eye condition that can raise the chance of exfoliation glaucoma. Large studies show that common LOXL1 gene variants are linked to exfoliation glaucoma and related eye findings, but they do not guarantee that a person will develop disease. These associations are strongest in population studies and can vary by ancestry.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply reflect natural human diversity. For many genes, having a variant associated with a condition points to a possible link, not a confirmed diagnosis, especially when several genes and environmental influences play a role. In some situations, though, one well characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For LOXL1, risk is shaped by more than the gene itself. Age is an important factor, and risk for the related eye condition can also vary by ancestry and where you live. Sunlight exposure and other environmental factors may play a part, but the gene change alone does not mean someone will definitely develop disease.
Inheritance of LOXL1 variants
There is not yet a broadly confirmed single Mendelian inheritance pattern for LOXL1-related health effects. In practice, how LOXL1 gene variants are inherited is less straightforward than for genes that clearly follow an autosomal dominant or autosomal recessive pattern. The LOXL1 gene is located on chromosome 15, which is an autosome, so you inherit one copy from each parent. This means LOXL1 variants can be passed through families on either side, but their effect on health can vary widely.
What does my LOXL1 result mean for my family?
There is not yet a broadly confirmed family inheritance pattern for LOXL1 tied to one specific genetic condition in the way seen with some single-gene diseases. A LOXL1 result often relates more to changing risk than to predicting that relatives will definitely have the same health problem, so family meaning depends on the exact result and the condition being considered.
Genetic information
Genetic testing
How you find out about variants
LOXL1 genetic testing uses a saliva or blood sample to read the DNA sequence and look for variants in the LOXL1 gene. Results can show whether you carry changes linked to a higher chance of certain eye conditions, but they do not confirm that disease will happen.
When should I consider getting a genetic test?
There is not yet a broadly established reason for LOXL1 testing on its own, because changes in this gene mainly affect risk rather than giving a clear yes-or-no answer about disease. Testing decisions are best made with a doctor or genetic counselor, especially if there is a strong family history of certain eye conditions such as exfoliation glaucoma.
A genetic result is only one part of your health story
Genetic findings can be informative, but how much they reveal varies by the condition and the kind of variant present. Over time, many factors shape how the body functions, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most useful when considered alongside other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Two people taking the same treatment may process it differently, which can change how well it works or how likely they are to notice side effects. These differences often relate to how the body absorbs, breaks down, transports, or responds to a drug. This is a common part of normal human variation and helps explain why medication response is not the same for everyone.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in a person’s genes affect the way they respond to medicines. It studies relationships between genes and drugs to understand why the same treatment can work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support treatment decisions that are more informed and more individualized. To learn more about this topic, you can explore the LearnHub.
Drugs influenced by the LOXL1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medicine choice or dose. If you have concerns about side effects, poor treatment response, or how your medicines fit with your health history, speak with your doctor or pharmacist.
History
The LOXL1 gene entered medical genetics through research on exfoliation syndrome, a common age related eye condition linked to glaucoma. In 2007, studies comparing DNA from large groups of affected and unaffected people identified common LOXL1 variants strongly associated with this condition, marking a major step in glaucoma research. From these first observations, research expanded steadily, with teams in Europe, the United States, and Asia confirming the link in many populations. Later work showed that the same LOXL1 variants do not have identical effects in every ancestry group, which helped refine how genetic risk is interpreted. This history made the LOXL1 gene an important example of how a gene discovery can be highly informative while still needing careful population specific understanding.